RGT 3.13% 33.0¢ argent biopharma limited

Ann: 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL, page-5

  1. 275 Posts.
    lightbulb Created with Sketch. 183
    For the sake of the World, and a Future where Covid -will be with us forever, this wonder drug would be a Godsend.

    The only part I am concerned about -- is Most deaths seem to be a result of patients with Comorbities ( Diabiities, Hypertension, Cerebrovascular Disease, Heart Failure, CKD stage>3, Dementia etc etc..) . and from a report I just read the length of stay averaged at 21 days or with death Length of stay is 14 days..

    https://hotcopper.com.au/data/attachments/3354/3354529-5fde1eb3f0b22dd054a8e8b5a133e0aa.jpg
    As I said -- I hope this wonder drug does work...
    But HOW DO YOU RUN A TEST OVER 28 TWENTY EIGHT DAYS when the hospitalisation periods is less then average case.

    To find over 250 patients or test samples for the 28day tests --- would continue to provide an Incomplete or Inconclusive Result.

    Looks great on paper and will surely bolster the share price short term --- But is it plausable?
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.010(3.13%)
Mkt cap ! $15.97M
Open High Low Value Volume
32.0¢ 34.0¢ 32.0¢ $1.401K 4.24K

Buyers (Bids)

No. Vol. Price($)
1 375 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 662 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.